Abstract
The RT-PCR method with real-time fluorescence detection was used for the development of a prototype of a diagnostic kit for reliable diagnosis of genetic variants of RNA of HIV-1 groups M, N, O, and P and RNA of HIV-2 in blood plasma and serum. The kit is tolerant to nucleotide mismatches, provides a broad linear range of concentrations of HIV RNA, 100% analytical specificity, and adequate analytical sensitivity: 42 ME/mL (HIV-1 group M), 45 copies/mL (HIV-2), 92 copies/mL (HIV-1 group O), and 90 copies/mL (HIV-1 group N). The kit provided successful detection and measurement of HIV RNA concentration in all the samples of the international reference panel for HIV-1 genotypes. The results of the test correlate with the results of commercial tests.
Similar content being viewed by others
References
Global report: UNAIDS report on the global AIDS epidemic. 2012.
Chamberland, M.E., Lackritz, E.M., and Busch, M.P., HIV screening of the blood supply in developed and developing countries, AIDS Rev., 2001, vol. 3, pp. 24–35.
Plantier, J.C., Leoz, M., Dickerson, J.E., De Oliveira, F., Condonnier, F., Lemée, V., et al., A new human immunodeficiency virus derived from gorillas, Nat. Med., 2009, vol. 15, no. 8, pp. 871–872.
McCutchan, F.E., Global epidemiology of HIV, J. Med. Virol., 2006, vol. 78, pp. 7–12.
Gould, K., Infection with HIV-1 group O, AIDS, 1997, vol. 11, no. 6, pp. 399–405.
Henquell, C., Jacomet, C., Antoniotti, O., Chaib, A., Regagnon, C., Brunet, S., et al., Difficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection, J. Clin. Microbiol., 2008, vol. 46, no. 7, pp. 2453–2456.
Aghokeng, A.F., Mpoudi-Ngole, E., Dimodi, H., Atem-Tambel, A., Tongo, M., Butel, C., et al., Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon, PLoS One, 2009, vol. 4, no. 11, pp. 7702–7707.
Damond, F., Worobey, M., Campa, P., Farfara, I., Colin, G., Matheron, S., et al., Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification, AIDS Res. Hum. Retroviruses, 2004, vol. 20, no. 6, pp. 666–672.
Ibe, S., Yokomaku, Y., Shiino, T., Tanaka, R., Hattori, J., Fujisaki, S., et al., HIV-2 CRF01-AB: first circulating recombinant form of HIV-2, J. Acquir. Immune. Defic. Syndr., 2010, vol. 54, no. 3, pp. 241–247.
Peterson, K., Jallow, S., Rowland-Jones, S.L., and de Silva, T.I., Antiretroviral therapy for HIV-2 infection: recommendations for management in low-resource settings, AIDS Res. Treat., 2011, Article ID 463704.
Matheron, S., Pueyo, S., Damond, F., Simon, F., Lepretre, A., Campa, P., et al., Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort, AIDS, 2003, vol. 17, no. 18, pp. 2593–2601.
Prasolova, M.A., Ivanov, M.K., and Dymshits, G.M., The development of an ultrasensitive mismatch tolerant PCR assay for detection and quantitation of HIV-1 RNA, Vopr. Virusol., 2011, vol. 56, no. 1, pp. 24–29.
Finney, D.J., Probit Analysis, Cambridge: Univ. Press, 1980, 3d ed.
Holmes, H., Davis, C., and Heath, A., Development of the 1st International Reference Panel for HIV-1 RNA genotypes for use in nucleic acid-based techniques, J. Virol. Methods, 2008, vol. 154, pp. 86–91.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M.A. Prasolova, M.K. Ivanov, N.M. Gashnikova, E.S. Netesova, G.M. Dymshits, 2014, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 2014, No. 4, pp. 20–25.
About this article
Cite this article
Prasolova, M.A., Ivanov, M.K., Gashnikova, N.M. et al. A Single-tube real-time RT-PCR assay for RNA detection and quantification of genetically diverse HIV including rare HIV-1 non-m groups and HIV-2. Mol. Genet. Microbiol. Virol. 29, 179–185 (2014). https://doi.org/10.3103/S0891416814040089
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0891416814040089